Recent advances in galactose-engineered nanocarriers for the site-specific delivery of siRNA and anticancer drugs
•Glycone recognition is a futuristic platform for active targeting.•Galactose is widely explored carbohydrate ligand for targeted drug delivery.•Recent advances of various galactosylated nano-carriers for tumor-targeting are overviewed.•Galactosylated nano-carriers may be considered as safe and effe...
Gespeichert in:
Veröffentlicht in: | Drug discovery today 2018-05, Vol.23 (5), p.960-973 |
---|---|
Hauptverfasser: | , , , , , , , , |
Format: | Artikel |
Sprache: | eng |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
Schreiben Sie den ersten Kommentar!